516 Delaware St. SE, Clinic 4B
Minneapolis, MN 55455
Philosophy of Care:I am dedicated to providing patients with as much information about their medical condition as possible, so that they can fully participate in choices for their treatment and medical care.
Mpls. St. Paul Magazine 2012 Top Doctor
Tang WHW, Francis GS. Should cardiac resynchronization therapy be used in patients with class I-II heart failure with a wide QRS? Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS. Circulation 2011: 203-208.
Tang WH, Francis GS. Statin treatment for patients with heart failure. Nat Rev Cardiol 2010; 7:249-55.
Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119:1977-2016.
Khot UN, Norvaro GM, Popovic Z, Mills R, Thomas JD, Tuzcu EM, Hammer D, Nissen SE, Francis GS. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003; 348:1756-1763.
Francis GS, Alpert JS (Editors). Coronary Care. 2nd Edition. Boston;Little, Brown and Company, pp. 3-804, 1995.
Cohn JN, Johnson G, Ziesche S, Cobb F, Francis GS, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Carson P, Cintron G, Shabetai R, Haakenson, C. A comparison of enalapril with hydralazine - isosorbide dinitrate in the treatment of chronic congestive heart failure: V-HeFT II. N Engl J Med 1991; 325:303-310.
Francis GS, Benedict C, Johnston DE, Kirlin PC, Nicklas J, Liange C-S, Kubo SH, Toretsky-Rudin E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990:82; 1724-1729.
Cohn JN, Archibald D, Ziesche S, Franciosa JA, Harston WE, Tristani F, Dunkman B, Jacobs W, Francis GS, Flohr K, Goldman S, Cobb F, Shah P, Saunders R, Fletcher R, Loeb H, Hughes V, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med 1986; 314:1547-1552.
Francis GS. Sodium and water excretion in heart failure: Efficacy of treatment has surpassed knowledge of pathophysiology. (Editorial). Ann Intern Med 1986;105:272-274.
Francis GS, Siegel R, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. The acute vasoconstrictor response of intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 1985; 103:1-6.